Aptevo Therapeutics (APVO) Receivables (2015 - 2019)
Aptevo Therapeutics (APVO) reported Receivables of $7.02 million for Q4 2019, up 34.5% from $5.22 million a year earlier but down 11.3% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Receivables (2015 - 2019) Analysis & Trends
Dating back to Q4 2015, Aptevo Therapeutics' Receivables record includes 16 quarters.
- Receivables has increased for three consecutive years, with a four-year compound annual growth rate of 2.1% (FY2015 to FY2019).
- By year, Receivables came in at $5.22 million in FY2018 (+143.8%), $2.14 million in FY2017 (+597.4%), $307,000 in FY2016 (-95.2%) and $6.46 million in FY2015.
- Five-year quarterly Receivables spans a low of $307,000 in Q4 2016 and a high of $8.51 million in Q2 2016.
- Year over year, Receivables has now increased in each of the last five quarters, with growth averaging 57.8% over the last seven quarters.
- The high point for year-over-year Receivables in five years was Q4 2017 (growth of 597.4%); the low point was Q4 2016 (a decline of 95.2%).
- Per Business Quant data, the three quarters before Q4 2019 came in at $7.92 million (Q3 2019), $7.38 million (Q2 2019) and $5.8 million (Q1 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Aptevo Therapeutics | 1.94 Mn | -65.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 7.02 Mn |
| Sep 30, 2019 | 7.92 Mn |
| Jun 30, 2019 | 7.38 Mn |
| Mar 31, 2019 | 5.80 Mn |
| Dec 31, 2018 | 5.22 Mn |
| Sep 30, 2018 | 6.20 Mn |
| Jun 30, 2018 | 6.15 Mn |
| Mar 31, 2018 | 3.10 Mn |
| Dec 31, 2017 | 2.14 Mn |
| Sep 30, 2017 | 528,000.00 |
| Jun 30, 2017 | 4.72 Mn |
| Mar 31, 2017 | 1.93 Mn |
| Dec 31, 2016 | 307,000.00 |
| Sep 30, 2016 | 2.96 Mn |
| Jun 30, 2016 | 8.51 Mn |
| Dec 31, 2015 | 6.46 Mn |
API Access
Aptevo Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();